SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Björn H. Falkenburger, Theodora Saridaki, Elisabeth Dinter, Cellular models for Parkinson's disease, Journal of Neurochemistry, 2016, 137, 3
  2. 2
    Gabriel Gustafsson, Fredrik Eriksson, Christer Möller, Tomás Lopes da Fonseca, Tiago F. Outeiro, Lars Lannfelt, Joakim Bergström, Martin Ingelsson, Cellular Uptake of α-Synuclein Oligomer-Selective Antibodies is Enhanced by the Extracellular Presence of α-Synuclein and Mediated via Fcγ Receptors, Cellular and Molecular Neurobiology, 2016,

    CrossRef

  3. 3
    Laura Pieri, Karine Madiona, Ronald Melki, Structural and functional properties of prefibrillar α-synuclein oligomers, Scientific Reports, 2016, 6, 24526

    CrossRef

  4. 4
    Anna Villar-Piqué, Tomás Lopes da Fonseca, Tiago Fleming Outeiro, Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies, Journal of Neurochemistry, 2016, 137, 3
  5. 5
    Lenka Schorova, Stéphane Martin, Sumoylation in Synaptic Function and Dysfunction, Frontiers in Synaptic Neuroscience, 2016, 8,

    CrossRef

  6. 6
    Laura Calo, Michal Wegrzynowicz, Jessica Santivañez-Perez, Maria Grazia Spillantini, Synaptic failure and α-synuclein, Movement Disorders, 2016, 31, 2
  7. 7
    Camilla Lööv, Clemens R. Scherzer, Bradley T. Hyman, Xandra O. Breakefield, Martin Ingelsson, α-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities, Cellular and Molecular Neurobiology, 2016, 36, 3, 437

    CrossRef

  8. 8
    Diana G. Ferreira, Vânia L. Batalha, Hugo Vicente Miranda, Joana E. Coelho, Rui Gomes, Francisco Q. Gonçalves, Joana I. Real, José Rino, António Albino-Teixeira, Rodrigo A. Cunha, Tiago F. Outeiro, Luísa V. Lopes, Adenosine A2AReceptors Modulate α-Synuclein Aggregation and Toxicity, Cerebral Cortex, 2015, bhv268

    CrossRef

  9. 9
    Andreas A. Deeg, Anne M. Reiner, Felix Schmidt, Florian Schueder, Sergey Ryazanov, Viktoria C. Ruf, Karin Giller, Stefan Becker, Andrei Leonov, Christian Griesinger, Armin Giese, Wolfgang Zinth, Anle138b and related compounds are aggregation specific fluorescence markers and reveal high affinity binding to α-synuclein aggregates, Biochimica et Biophysica Acta (BBA) - General Subjects, 2015, 1850, 9, 1884

    CrossRef

  10. 10
    Maria Antònia Busquets, Alba Espargaró, Joan Estelrich, Raimon Sabate, Couldα-Synuclein Amyloid-Like Aggregates Trigger a Prionic Neuronal Invasion?, BioMed Research International, 2015, 2015, 1

    CrossRef

  11. 11
    Daniel Ysselstein, Mehul Joshi, Vartika Mishra, Amy M. Griggs, Josephat M. Asiago, George P. McCabe, Lia A. Stanciu, Carol Beth Post, Jean-Christophe Rochet, Effects of impaired membrane interactions on α-synuclein aggregation and neurotoxicity, Neurobiology of Disease, 2015, 79, 150

    CrossRef

  12. 12
    Roeland Vanhauwaert, Patrik Verstreken, Flies with Parkinson's disease, Experimental Neurology, 2015, 274, 42

    CrossRef

  13. 13
    Igor F. Tsigelny, Yuriy Sharikov, Valentina L. Kouznetsova, Jerry P. Greenberg, Wolf Wrasidlo, Cassia Overk, Tania Gonzalez, Margarita Trejo, Brian Spencer, Kori Kosberg, Eliezer Masliah, Molecular Determinants of α-Synuclein Mutants’ Oligomerization and Membrane Interactions, ACS Chemical Neuroscience, 2015, 6, 3, 403

    CrossRef

  14. 14
    Shohreh Majd, John H. Power, Hugh J. M. Grantham, Neuronal response in Alzheimer’s and Parkinson’s disease: the effect of toxic proteins on intracellular pathways, BMC Neuroscience, 2015, 16, 1

    CrossRef

  15. 15
    Tessandra Stewart, Vesna Sossi, Jan O Aasly, Zbigniew K Wszolek, Ryan J Uitti, Kazuko Hasegawa, Teruo Yokoyama, Cyrus P Zabetian, James B Leverenz, Alexander Jon Stoessl, Yu Wang, Carmen Ginghina, Changqin Liu, Kevin C Cain, Peggy Auinger, Un Jung Kang, Poul Henning Jensen, Min Shi, Jing Zhang, Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity, Acta Neuropathologica Communications, 2015, 3, 1

    CrossRef

  16. 16
    Wei Xiang, Stefanie Menges, Johannes Schlachetzki, Holger Meixner, Anna-Carin Hoffmann, Ursula Schlötzer-Schrehardt, Cord-Michael Becker, Jürgen Winkler, Jochen Klucken, Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity, Molecular Neurodegeneration, 2015, 10, 1, 8

    CrossRef

  17. 17
    Mathieu Bourdenx, Nikolaos Stavros Koulakiotis, Despina Sanoudou, Erwan Bezard, Benjamin Dehay, Anthony Tsarbopoulos, Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies, Progress in Neurobiology, 2015,

    CrossRef

  18. 18
    C. Breda, M. L. Nugent, J. G. Estranero, C. P. Kyriacou, T. F. Outeiro, J. R. Steinert, F. Giorgini, Rab11 modulates  -synuclein-mediated defects in synaptic transmission and behaviour, Human Molecular Genetics, 2015, 24, 4, 1077

    CrossRef

  19. 19
    Xiaofeng Zhao, Xicui Sun, Song Cai, Dongzhi Ran, Ying Yan, Zhong Pei, Role of α-synuclein in cognitive dysfunction: Studies in Drosophila�melanogaster, Molecular Medicine Reports, 2015,

    CrossRef

  20. 20
    Hazel Roberts, David Brown, Seeking a Mechanism for the Toxicity of Oligomeric α-Synuclein, Biomolecules, 2015, 5, 2, 282

    CrossRef

  21. 21
    Laura Tosatto, Mathew H. Horrocks, Alexander J. Dear, Tuomas P. J. Knowles, Mauro Dalla Serra, Nunilo Cremades, Christopher M. Dobson, David Klenerman, Single-molecule FRET studies on alpha-synuclein oligomerization of Parkinson’s disease genetically related mutants, Scientific Reports, 2015, 5, 16696

    CrossRef

  22. 22
    Belém Sampaio-Marques, Paula Ludovico, Sirtuins and Proteolytic Systems: Implications for Pathogenesis of Synucleinopathies, Biomolecules, 2015, 5, 2, 735

    CrossRef

  23. 23
    Sudhakar Parthasarathy, Masafumi Inoue, Yiling Xiao, Yoshitaka Matsumura, Yo-ichi Nabeshima, Minako Hoshi, Yoshitaka Ishii, Structural Insight into an Alzheimer’s Brain-Derived Spherical Assembly of Amyloid β by Solid-State NMR, Journal of the American Chemical Society, 2015, 137, 20, 6480

    CrossRef

  24. 24
    Jose A. Rodriguez, Magdalena I. Ivanova, Michael R. Sawaya, Duilio Cascio, Francis E. Reyes, Dan Shi, Smriti Sangwan, Elizabeth L. Guenther, Lisa M. Johnson, Meng Zhang, Lin Jiang, Mark A. Arbing, Brent L. Nannenga, Johan Hattne, Julian Whitelegge, Aaron S. Brewster, Marc Messerschmidt, Sébastien Boutet, Nicholas K. Sauter, Tamir Gonen, David S. Eisenberg, Structure of the toxic core of α-synuclein from invisible crystals, Nature, 2015, 525, 7570, 486

    CrossRef

  25. 25
    Benjamin Dehay, Mathieu Bourdenx, Philippe Gorry, Serge Przedborski, Miquel Vila, Stéphane Hunot, Andrew Singleton, C Warren Olanow, Kalpana M Merchant, Erwan Bezard, Gregory A Petsko, Wassilios G Meissner, Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations, The Lancet Neurology, 2015, 14, 8, 855

    CrossRef

  26. 26
    J. Schapansky, J.D. Nardozzi, M.J. LaVoie, The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson’s disease, Neuroscience, 2015, 302, 74

    CrossRef

  27. 27
    Xi Chen, Jeff W. Barclay, Robert D. Burgoyne, Alan Morgan, Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases, Chemistry Central Journal, 2015, 9, 1

    CrossRef

  28. 28
    Guy A. Caldwell, Kim A. Caldwell, Movement Disorders, 2015,

    CrossRef

  29. 29
    Brian E. Staveley, Movement Disorders, 2015,

    CrossRef

  30. 30
    Ru-Huei Fu, Yu-Chi Wang, Chang-Shi Chen, Rong-Tzong Tsai, Shih-Ping Liu, Wen-Lin Chang, Hsin-Lien Lin, Chia-Hui Lu, Jing-Rong Wei, Zih-Wan Wang, Woei-Cherng Shyu, Shinn-Zong Lin, Acetylcorynoline attenuates dopaminergic neuron degeneration and α-synuclein aggregation in animal models of Parkinson's disease, Neuropharmacology, 2014, 82, 108

    CrossRef

  31. 31
    Patricia M. Chege, Gawain McColl, Caenorhabditis elegans: a model to investigate oxidative stress and metal dyshomeostasis in Parkinson's disease, Frontiers in Aging Neuroscience, 2014, 6,

    CrossRef

  32. 32
    Jing L Guo, Virginia M Y Lee, Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases, Nature Medicine, 2014, 20, 2, 130

    CrossRef

  33. 33
    Lucilla Parnetti, Davide Chiasserini, Emanuele Persichetti, Paolo Eusebi, Shiji Varghese, Mohammad M. Qureshi, Andrea Dardis, Marta Deganuto, Claudia Carlo, Anna Castrioto, Chiara Balducci, Silvia Paciotti, Nicola Tambasco, Bruno Bembi, Laura Bonanni, Marco Onofrj, Aroldo Rossi, Tommaso Beccari, Omar El-Agnaf, Paolo Calabresi, Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease, Movement Disorders, 2014, 29, 8
  34. 34
    Harald Depner, Janine Lützkendorf, Husam A Babkir, Stephan J Sigrist, Matthew G Holt, Differential centrifugation–based biochemical fractionation of the Drosophila adult CNS, Nature Protocols, 2014, 9, 12, 2796

    CrossRef

  35. 35
    Giuliana Fusco, Alfonso De Simone, Tata Gopinath, Vitaly Vostrikov, Michele Vendruscolo, Christopher M. Dobson, Gianluigi Veglia, Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour, Nature Communications, 2014, 5,

    CrossRef

  36. 36
    Cindie Eugene, Rozita Laghaei, Normand Mousseau, Early oligomerization stages for the non-amyloid component of α-synuclein amyloid, The Journal of Chemical Physics, 2014, 141, 13, 135103

    CrossRef

  37. 37
    Hao Deng, Lamei Yuan, Genetic variants and animal models in SNCA and Parkinson disease, Ageing Research Reviews, 2014, 15, 161

    CrossRef

  38. 38
    Veronica Lindström, Elisabet Ihse, Therese Fagerqvist, Joakim Bergström, Eva Nordström, Christer Möller, Lars Lannfelt, Martin Ingelsson, Immunotherapy targeting α-synuclein, with relevance for future treatment of Parkinson’s disease and other Lewy body disorders, Immunotherapy, 2014, 6, 2, 141

    CrossRef

  39. 39
    Cristian Follmer, Monoamine oxidase and α-synuclein as targets in Parkinson’s disease therapy, Expert Review of Neurotherapeutics, 2014, 14, 6, 703

    CrossRef

  40. 40
    Chrisna Swart, William Haylett, Craig Kinnear, Glynis Johnson, Soraya Bardien, Ben Loos, Neurodegenerative disorders: Dysregulation of a carefully maintained balance?, Experimental Gerontology, 2014, 58, 279

    CrossRef

  41. 41
    Shun Yu, Piu Chan, Role of α-synuclein in neurodegeneration: implications for the pathogenesis of Parkinson's disease, Essays In Biochemistry, 2014, 56, 125

    CrossRef

  42. 42
    Shruti Sahay, A. Anoop, G. Krishnamoorthy, Samir K. Maji, Site-Specific Fluorescence Dynamics of α-Synuclein Fibrils Using Time-Resolved Fluorescence Studies: Effect of Familial Parkinson’s Disease-Associated Mutations, Biochemistry, 2014, 53, 5, 807

    CrossRef

  43. 43
    Luis Fonseca-Ornelas, Sybille E. Eisbach, Maria Paulat, Karin Giller, Claudio O. Fernández, Tiago F. Outeiro, Stefan Becker, Markus Zweckstetter, Small molecule-mediated stabilization of vesicle-associated helical α-synuclein inhibits pathogenic misfolding and aggregation, Nature Communications, 2014, 5, 5857

    CrossRef

  44. 44
    Johannes Levin, Felix Schmidt, Cathrin Boehm, Catharina Prix, Kai Bötzel, Sergey Ryazanov, Andrei Leonov, Christian Griesinger, Armin Giese, The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset, Acta Neuropathologica, 2014, 127, 5, 779

    CrossRef

  45. 45
    O. Chutna, S. Goncalves, A. Villar-Pique, P. Guerreiro, Z. Marijanovic, T. Mendes, J. Ramalho, E. Emmanouilidou, S. Ventura, J. Klucken, D. C. Barral, F. Giorgini, K. Vekrellis, T. F. Outeiro, The small GTPase Rab11 co-localizes with  -synuclein in intracellular inclusions and modulates its aggregation, secretion and toxicity, Human Molecular Genetics, 2014, 23, 25, 6732

    CrossRef

  46. 46
    Raimon Sabate, When amyloids become prions, Prion, 2014, 8, 3, 233

    CrossRef

  47. 47
    Raimon Sabate, When amyloids become prions, Prion, 2014, 8, 3

    CrossRef

  48. 48
    Guowei Yin, Tomas Lopes da Fonseca, Sibylle E. Eisbach, Ane Martín Anduaga, Carlo Breda, Maria L. Orcellet, Éva M. Szegő, Patricia Guerreiro, Diana F. Lázaro, Gerhard H. Braus, Claudio O. Fernandez, Christian Griesinger, Stefan Becker, Roger S. Goody, Aymelt Itzen, Flaviano Giorgini, Tiago F. Outeiro, Markus Zweckstetter, α-Synuclein interacts with the switch region of Rab8a in a Ser129 phosphorylation-dependent manner, Neurobiology of Disease, 2014, 70, 149

    CrossRef

  49. 49
    Alireza Roostaee, Simon Beaudoin, Antanas Staskevicius, Xavier Roucou, Aggregation and neurotoxicity of recombinant α-synuclein aggregates initiated by dimerization, Molecular Neurodegeneration, 2013, 8, 1, 5

    CrossRef

  50. 50
    Sibylle E. Eisbach, Tiago F. Outeiro, alpha-Synuclein and intracellular trafficking: impact on the spreading of Parkinson’s disease pathology, Journal of Molecular Medicine, 2013, 91, 6, 693

    CrossRef

  51. 51
    Jens Wagner, Sergey Ryazanov, Andrei Leonov, Johannes Levin, Song Shi, Felix Schmidt, Catharina Prix, Francisco Pan-Montojo, Uwe Bertsch, Gerda Mitteregger-Kretzschmar, Markus Geissen, Martin Eiden, Fabienne Leidel, Thomas Hirschberger, Andreas A. Deeg, Julian J. Krauth, Wolfgang Zinth, Paul Tavan, Jens Pilger, Markus Zweckstetter, Tobias Frank, Mathias Bähr, Jochen H. Weishaupt, Manfred Uhr, Henning Urlaub, Ulrike Teichmann, Matthias Samwer, Kai Bötzel, Martin Groschup, Hans Kretzschmar, Christian Griesinger, Armin Giese, Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease, Acta Neuropathologica, 2013, 125, 6, 795

    CrossRef

  52. 52
    Ali Chaari, Jessica Hoarau-Véchot, Moncef Ladjimi, Applying chaperones to protein-misfolding disorders: Molecular chaperones against α-synuclein in Parkinson's disease, International Journal of Biological Macromolecules, 2013, 60, 196

    CrossRef

  53. 53
    Hisanori Iwasa, Hiroshi Kameda, Naoya Fukui, Sakiho Yoshida, Kunihiro Hongo, Tomohiro Mizobata, Saori Kobayashi, Yasushi Kawata, Bilberry Anthocyanins Neutralize the Cytotoxicity of Co-Chaperonin GroES Fibrillation Intermediates, Biochemistry, 2013, 52, 51, 9202

    CrossRef

  54. 54
    Pradeep K. Singh, Vasudha Kotia, Dhiman Ghosh, Ganesh M. Mohite, Ashutosh Kumar, Samir K. Maji, Curcumin Modulates α-Synuclein Aggregation and Toxicity, ACS Chemical Neuroscience, 2013, 4, 3, 393

    CrossRef

  55. 55
    Kai-Li Ma, Lian-Kun Song, Whitney Annie Long, Yu-He Yuan, Ying Zhang, Xiu-Yun Song, Fei Niu, Ning Han, Nai-Hong Chen, Deletion in exon 5 of the SNCA gene and exposure to rotenone leads to oligomerization of α-synuclein and toxicity to PC12 cells, Brain Research Bulletin, 2013, 90, 127

    CrossRef

  56. 56
    Santiago Esteban-Martín, Jordi Silvestre-Ryan, Carlos W. Bertoncini, Xavier Salvatella, Identification of Fibril-Like Tertiary Contacts in Soluble Monomeric α-Synuclein, Biophysical Journal, 2013, 105, 5, 1192

    CrossRef

  57. 57
    S. Pornsuwan, K. Giller, D. Riedel, S. Becker, C. Griesinger, M. Bennati, Long-Range Distances in Amyloid Fibrils of α-Synuclein from PELDOR Spectroscopy, Angewandte Chemie, 2013, 125, 39
  58. 58
    S. Pornsuwan, K. Giller, D. Riedel, S. Becker, C. Griesinger, M. Bennati, Long-Range Distances in Amyloid Fibrils of α-Synuclein from PELDOR Spectroscopy, Angewandte Chemie International Edition, 2013, 52, 39
  59. 59
    Angelique Camilleri, Claire Zarb, Mario Caruana, Ulrike Ostermeier, Stephanie Ghio, Tobias Högen, Felix Schmidt, Armin Giese, Neville Vassallo, Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols, Biochimica et Biophysica Acta (BBA) - Biomembranes, 2013, 1828, 11, 2532

    CrossRef

  60. 60
    Cecilia Chavarría, José M. Souza, Oxidation and nitration of α-synuclein and their implications in neurodegenerative diseases, Archives of Biochemistry and Biophysics, 2013, 533, 1-2, 25

    CrossRef

  61. 61
    Wei Xiang, Johannes C.M. Schlachetzki, Stefan Helling, Julia C. Bussmann, Marvin Berlinghof, Tilman E. Schäffer, Katrin Marcus, Jürgen Winkler, Jochen Klucken, Cord-Michael Becker, Oxidative stress-induced posttranslational modifications of alpha-synuclein: Specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity, Molecular and Cellular Neuroscience, 2013, 54, 71

    CrossRef

  62. 62
    Luc Bousset, Laura Pieri, Gemma Ruiz-Arlandis, Julia Gath, Poul Henning Jensen, Birgit Habenstein, Karine Madiona, Vincent Olieric, Anja Böckmann, Beat H. Meier, Ronald Melki, Structural and functional characterization of two alpha-synuclein strains, Nature Communications, 2013, 4,

    CrossRef

  63. 63
    Petranka Krumova, Jochen H. Weishaupt, Sumoylation in neurodegenerative diseases, Cellular and Molecular Life Sciences, 2013, 70, 12, 2123

    CrossRef

  64. 64
    Dhiman Ghosh, Mrityunjoy Mondal, Ganesh M. Mohite, Pradeep K. Singh, Priyatosh Ranjan, A. Anoop, Saikat Ghosh, Narendra Nath Jha, Ashutosh Kumar, Samir K. Maji, The Parkinson’s Disease-Associated H50Q Mutation Accelerates α-Synuclein Aggregationin Vitro, Biochemistry, 2013, 52, 40, 6925

    CrossRef

  65. 65
    Angélique Deleersnijder, Melanie Gerard, Zeger Debyser, Veerle Baekelandt, The remarkable conformational plasticity of alpha-synuclein: blessing or curse?, Trends in Molecular Medicine, 2013, 19, 6, 368

    CrossRef

  66. 66
    Jung Nam Kim, Min Kyeong Kim, Kyu Suk Cho, Chang Soon Choi, Seung Hwa Park, Sung-Il Yang, So Hyun Joo, Jin Hee Park, Geonho Bahn, Chan Young Shin, He-Jin Lee, Seol-Heui Han, Kyoung Ja Kwon, Valproic Acid Regulates α-Synuclein Expression through JNK Pathway in Rat Primary Astrocytes, Biomolecules and Therapeutics, 2013, 21, 3, 222

    CrossRef

  67. 67
    Lorraine V. Kalia, Suneil K. Kalia, Pamela J. McLean, Andres M. Lozano, Anthony E. Lang, α-Synuclein oligomers and clinical implications for Parkinson disease, Annals of Neurology, 2013, 73, 2
  68. 68
    Cintia Roodveldt, August Andersson, Erwin J. De Genst, Adahir Labrador-Garrido, Alexander K. Buell, Christopher M. Dobson, Gian Gaetano Tartaglia, Michele Vendruscolo, A Rationally Designed Six-Residue Swap Generates Comparability in the Aggregation Behavior of α-Synuclein and β-Synuclein, Biochemistry, 2012, 51, 44, 8771

    CrossRef

  69. 69
    Éva M. Szegő, Ellen Gerhardt, Pawel Kermer, Jörg B. Schulz, A30P α-synuclein impairs dopaminergic fiber regeneration and interacts with L-DOPA replacement in MPTP-treated mice, Neurobiology of Disease, 2012, 45, 1, 591

    CrossRef

  70. 70
    Grit Taschenberger, Manuel Garrido, Yuliya Tereshchenko, Mathias Bähr, Markus Zweckstetter, Sebastian Kügler, Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons, Acta Neuropathologica, 2012, 123, 5, 671

    CrossRef

  71. 71
    O Marques, T F Outeiro, Alpha-synuclein: from secretion to dysfunction and death, Cell Death and Disease, 2012, 3, 7, e350

    CrossRef

  72. 72
    Fabio Blandini, Marie-Therese Armentero, Animal models of Parkinson’s disease, The FEBS Journal, 2012, 279, 7
  73. 73
    M. Zhou, G. Ottenberg, G. F. Sferrazza, C. I. Lasmezas, Highly neurotoxic monomeric  -helical prion protein, Proceedings of the National Academy of Sciences, 2012, 109, 8, 3113

    CrossRef

  74. 74
    Janelle Drouin-Ouellet, Francesca Cicchetti, Inflammation and neurodegeneration: the story ‘retolled’, Trends in Pharmacological Sciences, 2012, 33, 10, 542

    CrossRef

  75. 75
    Imola G. Zigoneanu, Yoo Jeong Yang, Alexander S. Krois, Md. Emdadul Haque, Gary J. Pielak, Interaction of α-synuclein with vesicles that mimic mitochondrial membranes, Biochimica et Biophysica Acta (BBA) - Biomembranes, 2012, 1818, 3, 512

    CrossRef

  76. 76
    Mario Caruana, Johanna Neuner, Tobias Högen, Felix Schmidt, Frits Kamp, Charles Scerri, Armin Giese, Neville Vassallo, Polyphenolic compounds are novel protective agents against lipid membrane damage by α-synuclein aggregates in vitro, Biochimica et Biophysica Acta (BBA) - Biomembranes, 2012, 1818, 11, 2502

    CrossRef

  77. 77
    Darius Ebrahimi-Fakhari, Lara Wahlster, Pamela J. McLean, Protein degradation pathways in Parkinson’s disease: curse or blessing, Acta Neuropathologica, 2012, 124, 2, 153

    CrossRef

  78. 78
    Eva K. McGuire, Michael Motskin, Benedetta Bolognesi, Shane D. Bergin, Tuomas P. J. Knowles, Jeremy Skepper, Leila M. Luheshi, David W. McComb, Christopher M. Dobson, Alexandra E. Porter, Selenium-Enhanced Electron Microscopic Imaging of Different Aggregate Forms of a Segment of the Amyloid β Peptide in Cells, ACS Nano, 2012, 6, 6, 4740

    CrossRef

  79. 79
    Jonathan A. Fauerbach, Dmytro A. Yushchenko, Sarah H. Shahmoradian, Wah Chiu, Thomas M. Jovin, Elizabeth A. Jares-Erijman, Supramolecular Non-Amyloid Intermediates in the Early Stages of α-Synuclein Aggregation, Biophysical Journal, 2012, 102, 5, 1127

    CrossRef

  80. 80
    Kostas Vekrellis, Leonidas Stefanis, Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies, Expert Opinion on Therapeutic Targets, 2012, 16, 4, 421

    CrossRef

  81. 81
    Kurt Jellinger, The role of α-synuclein in neurodegeneration — An update, Translational Neuroscience, 2012, 3, 2

    CrossRef

  82. 82
    María Soledad Celej, Rabia Sarroukh, Erik Goormaghtigh, Gerardo D. Fidelio, Jean-Marie Ruysschaert, Vincent Raussens, Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure, Biochemical Journal, 2012, 443, 3, 719

    CrossRef

  83. 83
    Tobias Högen, Johannes Levin, Felix Schmidt, Mario Caruana, Neville Vassallo, Hans Kretzschmar, Kai Bötzel, Frits Kamp, Armin Giese, Two Different Binding Modes of α-Synuclein to Lipid Vesicles Depending on its Aggregation State, Biophysical Journal, 2012, 102, 7, 1646

    CrossRef

  84. 84
    Jean-Christophe Rochet, Bruce A. Hay, Ming Guo, Molecular Biology of Neurodegenerative Diseases, 2012,

    CrossRef

  85. 85
    M. Baldus, Comprehensive Biophysics, 2012,

    CrossRef

  86. 86
    W. Wang, I. Perovic, J. Chittuluru, A. Kaganovich, L. T. T. Nguyen, J. Liao, J. R. Auclair, D. Johnson, A. Landeru, A. K. Simorellis, S. Ju, M. R. Cookson, F. J. Asturias, J. N. Agar, B. N. Webb, C. Kang, D. Ringe, G. A. Petsko, T. C. Pochapsky, Q. Q. Hoang, A soluble  -synuclein construct forms a dynamic tetramer, Proceedings of the National Academy of Sciences, 2011, 108, 43, 17797

    CrossRef

  87. 87
    Alice Y. Yam, Xuemei Wang, Carol Man Gao, Michael D. Connolly, Ronald N. Zuckermann, Thieu Bleu, John Hall, Joseph P. Fedynyshyn, Sophie Allauzen, David Peretz, Cleo M. Salisbury, A Universal Method for Detection of Amyloidogenic Misfolded Proteins, Biochemistry, 2011, 50, 20, 4322

    CrossRef

  88. 88
    Fiorella Malchiodi-Albedi, Silvia Paradisi, Andrea Matteucci, Claudio Frank, Marco Diociaiuti, Amyloid Oligomer Neurotoxicity, Calcium Dysregulation, and Lipid Rafts, International Journal of Alzheimer's Disease, 2011, 2011, 1

    CrossRef

  89. 89
    Jörg B. Schulz, Manfred Gerlach, Gabriele Gille, Wilfried Kuhn, Martina Müngersdorf, Peter Riederer, Martin Südmeyer, Albert Ludolph, Basic science in Parkinson’s disease: its impact on clinical practice, Journal of Neurology, 2011, 258, S2, 299

    CrossRef

  90. 90
    Min-Kyu Cho, Hai-Young Kim, Claudio O. Fernandez, Stefan Becker, Markus Zweckstetter, Conserved core of amyloid fibrils of wild type and A30P mutant α-synuclein, Protein Science, 2011, 20, 2
  91. 91
    Kenjiro Ono, Tokuhei Ikeda, Jun-ichi Takasaki, Masahito Yamada, Familial Parkinson disease mutations influence α-synuclein assembly, Neurobiology of Disease, 2011, 43, 3, 715

    CrossRef

  92. 92
    M. Decressac, A. Ulusoy, B. Mattsson, B. Georgievska, M. Romero-Ramos, D. Kirik, A. Bjorklund, GDNF fails to exert neuroprotection in a rat  -synuclein model of Parkinson's disease, Brain, 2011, 134, 8, 2302

    CrossRef

  93. 93
    B. Winner, R. Jappelli, S. K. Maji, P. A. Desplats, L. Boyer, S. Aigner, C. Hetzer, T. Loher, M. Vilar, S. Campioni, C. Tzitzilonis, A. Soragni, S. Jessberger, H. Mira, A. Consiglio, E. Pham, E. Masliah, F. H. Gage, R. Riek, In vivo demonstration that  -synuclein oligomers are toxic, Proceedings of the National Academy of Sciences, 2011, 108, 10, 4194

    CrossRef

  94. 94
    Mario Caruana, Tobias Högen, Johannes Levin, Andreas Hillmer, Armin Giese, Neville Vassallo, Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds, FEBS Letters, 2011, 585, 8
  95. 95
    Manuel Etzkorn, Anja Böckmann, Marc Baldus, Kinetic analysis of protein aggregation monitored by real-time 2D solid-state NMR spectroscopy, Journal of Biomolecular NMR, 2011, 49, 2, 121

    CrossRef

  96. 96
    Nicholas P. Reynolds, Alice Soragni, Michael Rabe, Dorinel Verdes, Ennio Liverani, Stephan Handschin, Roland Riek, Stefan Seeger, Mechanism of Membrane Interaction and Disruption by α-Synuclein, Journal of the American Chemical Society, 2011, 133, 48, 19366

    CrossRef

  97. 97
    Thomas Gasser, John Hardy, Yoshikuni Mizuno, Milestones in PD genetics, Movement Disorders, 2011, 26, 6
  98. 98
    Benjamin Dehay, Erwan Bezard, New animal models of Parkinson's disease, Movement Disorders, 2011, 26, 7
  99. 99
    Joshua M. Shulman, Philip L. De Jager, Mel B. Feany, Parkinson's Disease: Genetics and Pathogenesis, Annual Review of Pathology: Mechanisms of Disease, 2011, 6, 1, 193

    CrossRef

  100. 100
    Kostas Vekrellis, Maria Xilouri, Evangelia Emmanouilidou, Hardy J Rideout, Leonidas Stefanis, Pathological roles of α-synuclein in neurological disorders, The Lancet Neurology, 2011, 10, 11, 1015

    CrossRef

  101. 101
    Hélène Van Melckebeke, Paul Schanda, Julia Gath, Christian Wasmer, René Verel, Adam Lange, Beat H. Meier, Anja Böckmann, Probing Water Accessibility in HET-s(218–289) Amyloid Fibrils by Solid-State NMR, Journal of Molecular Biology, 2011, 405, 3, 765

    CrossRef

  102. 102
    Tiziana Alberio, Mauro Fasano, Proteomics in Parkinson's disease: An unbiased approach towards peripheral biomarkers and new therapies, Journal of Biotechnology, 2011, 156, 4, 325

    CrossRef

  103. 103
    Ran Friedman, Amedeo Caflisch, Surfactant Effects on Amyloid Aggregation Kinetics, Journal of Molecular Biology, 2011, 414, 2, 303

    CrossRef

  104. 104
    S. Fabio Falsone, Gerd Leitinger, Anita Karner, Andreas J. Kungl, Simone Kosol, Roberto Cappai, Klaus Zangger, The neurotransmitter serotonin interrupts α-synuclein amyloid maturation, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2011, 1814, 5, 553

    CrossRef

  105. 105
    Hideya Mizuno, Nobuhiro Fujikake, Keiji Wada, Yoshitaka Nagai, α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies, Parkinson's Disease, 2011, 2011, 1

    CrossRef

  106. 106
    Benjamin Wolozin, Christopher Gabel, Andrew Ferree, Maria Guillily, Atsushi Ebata, Animal Models of Human Disease, 2011,

    CrossRef

  107. 107
    Alexander J. Whitworth, 2011,

    CrossRef

  108. 108
    Karen A. Lewis, Yang Su, Olina Jou, Caroline Ritchie, Chan Foong, Linda S. Hynan, Charles L. White, Philip J. Thomas, Kimmo J. Hatanpaa, Abnormal Neurites Containing C-Terminally Truncated α-Synuclein Are Present in Alzheimer's Disease without Conventional Lewy Body Pathology, The American Journal of Pathology, 2010, 177, 6, 3037

    CrossRef

  109. 109
    Song Yi Bae, Seulgi Kim, Heejin Hwang, Hyun-Kyung Kim, Hyun C. Yoon, Jae Ho Kim, SangYoon Lee, T. Doohun Kim, Amyloid formation and disaggregation of α-synuclein and its tandem repeat (α-TR), Biochemical and Biophysical Research Communications, 2010, 400, 4, 531

    CrossRef

  110. 110
    Amyloide: Aggregate mit Aktivität, Nachrichten aus der Chemie, 2010, 58, 9
  111. You have free access to this content111
    Adam J. Harrington, Shusei Hamamichi, Guy A. Caldwell, Kim A. Caldwell, C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease, Developmental Dynamics, 2010, 239, 5
  112. 112
    Lukasz Skora, Stefan Becker, Markus Zweckstetter , Characterization of Amyloid Fibrils of Human β-2-Microglobulin by High-Resolution Magic-Angle Spinning NMR, ChemBioChem, 2010, 11, 13
  113. 113
    Yuichi Yoshimura, Kazumasa Sakurai, Young-Ho Lee, Takahisa Ikegami, Eri Chatani, Hironobu Naiki, Yuji Goto, Direct observation of minimum-sized amyloid fibrils using solution NMR spectroscopy, Protein Science, 2010, 19, 12
  114. 114
    Elizabeth R. Middleton, Elizabeth Rhoades, Effects of Curvature and Composition on α-Synuclein Binding to Lipid Vesicles, Biophysical Journal, 2010, 99, 7, 2279

    CrossRef

  115. 115
    Marie Renault, Abhishek Cukkemane, Marc Baldus, Festkörper-NMR-Spektroskopie an komplexen Biomolekülen, Angewandte Chemie, 2010, 122, 45
  116. 116
    Frits Kamp, Nicole Exner, Anne Kathrin Lutz, Nora Wender, Jan Hegermann, Bettina Brunner, Brigitte Nuscher, Tim Bartels, Armin Giese, Klaus Beyer, Stefan Eimer, Konstanze F Winklhofer, Christian Haass, Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1, The EMBO Journal, 2010, 29, 20
  117. 117
    Ann-Christin Brorsson, Benedetta Bolognesi, Gian Gaetano Tartaglia, Sarah L. Shammas, Giorgio Favrin, Ian Watson, David A. Lomas, Fabrizio Chiti, Michele Vendruscolo, Christopher M. Dobson, Damian C. Crowther, Leila M. Luheshi, Intrinsic Determinants of Neurotoxic Aggregate Formation by the Amyloid β Peptide, Biophysical Journal, 2010, 98, 8, 1677

    CrossRef

  118. 118
    Jean-Marc Taymans, Mark R. Cookson, Mechanisms in dominant parkinsonism: The toxic triangle of LRRK2, α-synuclein, and tau, BioEssays, 2010, 32, 3
  119. 119
    Mel B. Feany, New Approaches to the Pathology and Genetics of Neurodegeneration, The American Journal of Pathology, 2010, 176, 5, 2058

    CrossRef

  120. 120
    David R. Brown, Oligomeric alpha-synuclein and its role in neuronal death, IUBMB Life, 2010, 62, 5
  121. 121
    Marie Renault, Abhishek Cukkemane, Marc Baldus, Solid-State NMR Spectroscopy on Complex Biomolecules, Angewandte Chemie International Edition, 2010, 49, 45
  122. 122
    Maria F. Mossuto, Anne Dhulesia, Glyn Devlin, Erica Frare, Janet R. Kumita, Patrizia Polverino de Laureto, Mireille Dumoulin, Angelo Fontana, Christopher M. Dobson, Xavier Salvatella, The Non-Core Regions of Human Lysozyme Amyloid Fibrils Influence Cytotoxicity, Journal of Molecular Biology, 2010, 402, 5, 783

    CrossRef

  123. 123
    Agata Rekas, Robert B. Knott, Anna Sokolova, Kevin J. Barnham, Keyla A. Perez, Colin L. Masters, Simon C. Drew, Roberto Cappai, Cyril C. Curtain, Chi L. L. Pham, The structure of dopamine induced α-synuclein oligomers, European Biophysics Journal, 2010, 39, 10, 1407

    CrossRef

  124. 124
    Tjakko J. van Ham, Alessandro Esposito, Janet R. Kumita, Shang-Te D. Hsu, Gabriele S. Kaminski Schierle, Clemens F. Kaminski, Christopher M. Dobson, Ellen A.A. Nollen, Carlos W. Bertoncini, Towards Multiparametric Fluorescent Imaging of Amyloid Formation: Studies of a YFP Model of α-Synuclein Aggregation, Journal of Molecular Biology, 2010, 395, 3, 627

    CrossRef

  125. 125
    Thomas Gasser, Recent Advances in Parkinson’s Disease: Basic Research, 2010,

    CrossRef

  126. 126
    Elodie Angot, Patrik Brundin, Dissecting the potential molecular mechanisms underlying α-synuclein cell-to-cell transfer in Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, S143

    CrossRef

  127. 127
    Hai-Young Kim, Min-Kyu Cho, Ashutosh Kumar, Elke Maier, Carsten Siebenhaar, Stefan Becker, Claudio O. Fernandez, Hilal A. Lashuel, Roland Benz, Adam Lange, Markus Zweckstetter, Structural Properties of Pore-Forming Oligomers of α-Synuclein, Journal of the American Chemical Society, 2009, 131, 47, 17482

    CrossRef

  128. 128
    Christian Griesinger, Griesinger, Christian: Fascinated by NMR since 30 years, eMagRes,
  129. 129
    Giuseppe Arena, Enza Maria Valente, Mitochondria in Parkinson's Disease,
  130. 130
    References,
  131. 131
    Beat H. Meier, Structural Studies of Protein Fibrils and Misfolded Proteins by Solid-State NMR, eMagRes,
  132. 132
    Wolfgang Hoyer, Henrike Heise, What Does Solid-State NMR Tell Us about Amyloid Structures?,